Back

Postmenopausal hormone therapy and major adverse cardiac events in women with prior myocardial infarction

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Cardiovascular health in women: from hormones to high-risk conditions Cardiovascular Disease in Women ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Hannah Karin Wood-Kurland

Nordsjaellands Hospital, Hilleroed (Denmark)

4 More presentations in this session

Presentation thumbnail
Participation of women in cardiovascular trials from 2017 to 2023: a systematic review
Professor M. Gulati (Houston, US)
Abstract Slides Video
Presentation thumbnail
Gender differences in the performance of the Chest Pain score and modified HEART score in risk stratification for cardiac events in patients presenting to the Emergency Department with chest pain
Doctor L. Pelagatti (Florence, IT)
Abstract Slides Video
Presentation thumbnail
Cardiovascular risk in autoimmune diseases: associations and interactions with traditional risk factors in a prospective population-based cohort of 450 000 individuals
Mr A. Schuermans (Leuven, BE)
Abstract Slides Video
Presentation thumbnail
Distinct risk patterns of mid-trimester systolic-diastolic blood pressure for individual and co-occurring adverse pregnancy outcomes
Miss F. Yiwen (Tianjin, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular health in women: from hormones to high-risk conditions
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Heart failure in women: special considerations - discussion
thumbnail
Congress Presentation
Managing menopause in heart failure patients
thumbnail
Congress Presentation
From menarche to menopause: exploring hormonal influences on heart failure in women

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources